# OnCo record eu-pharma-package (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/eu-pharma-package/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "eu-pharma-package" ;
  schema:name "EU pharmaceutical package reform (2023 proposal)"@en ;
  schema:alternateName "pharmaceutical package"@en, "EU pharmaceutical legislation reform"@en, "pharma package"@en, "pharmaceutical strategy for Europe"@en, "regulatory data protection reform"@en, "transferable exclusivity voucher"@en, "modulated exclusivity"@en ;
  schema:description "The biggest rewrite of EU medicines law in twenty years, proposed in 2023: shorter default protection from generic competition with extensions for launching everywhere in the EU and for meeting unmet needs, faster assessments, and tighter orphan and paediatric rules, argued over by Parliament and Council since."@en ;
  schema:url <https://onco.cc/terms/eu-pharma-package/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://health.ec.europa.eu/medicinal-products/reform-eu-pharmaceutical-legislation_en> ;
  onco:tag "law", "eu" ;
  onco:related <https://onco.cc/terms/eu-data-exclusivity/>, <https://onco.cc/terms/eu-regulation-726-2004/>, <https://onco.cc/terms/eu-orphan-regulation/>, <https://onco.cc/terms/eu-paediatric-regulation/>, <https://onco.cc/terms/spc/>, <https://onco.cc/terms/conditional-approval/>, <https://onco.cc/terms/eu-hta-regulation/>, <https://onco.cc/terms/us-regulatory-exclusivity/>, <https://onco.cc/terms/biosimilar/> ;
  onco:institutions <https://onco.cc/institutions/ema/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-incentive-misalignment/> .